CXCR3 and neoplasm: Taken together, these data demonstrate a mechanism by which the response to cytotoxic therapy can be improved: TGFβ acts locally to suppress the transcription of CXCR3 thereby limiting tumor-infiltration; CD8+ T cells that do reach the tumor have an increased threshold for activation, decreased cytotoxicity, and decreased proliferation.